Summit Trail Advisors’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-233
| Closed | -$43.4K | – | 440 |
|
|
2024
Q3 | $43.4K | Hold |
233
| – | – | ﹤0.01% | 713 |
|
|
2024
Q2 | $39.9K | Hold |
233
| – | – | ﹤0.01% | 611 |
|
|
2024
Q1 | $100K | Hold |
233
| – | – | ﹤0.01% | 584 |
|
|
2023
Q4 | $205K | Hold |
233
| – | – | 0.01% | 497 |
|
|
2023
Q3 | $219K | Hold |
233
| – | – | 0.01% | 481 |
|
|
2023
Q2 | $225K | Hold |
233
| – | – | 0.01% | 449 |
|
|
2023
Q1 | $261K | Hold |
233
| – | – | 0.01% | 345 |
|
|
2022
Q4 | $153K | Hold |
233
| – | – | 0.01% | 373 |
|
|
2022
Q3 | $197K | Hold |
233
| – | – | 0.01% | 337 |
|
|
2022
Q2 | $202K | Hold |
233
| – | – | 0.01% | 352 |
|
|
2022
Q1 | $355K | Hold |
233
| – | – | 0.03% | 216 |
|
|
2021
Q4 | $290K | Hold |
233
| – | – | 0.02% | 235 |
|
|
2021
Q3 | $284K | Hold |
233
| – | – | 0.02% | 205 |
|
|
2021
Q2 | $187K | Buy |
+233
| New | +$187K | 0.02% | 209 |
|